| |
| |
|
| Insider
Information: |
Maddon Paul J |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
909,891 |
|
|
Indirect Shares
|
1,000 |
|
|
| Direct
Value |
$3,730,553 |
|
|
|
Indirect Value
|
$4,100 |
|
|
| Total
Shares |
910,891 |
|
|
| Total
Value |
$3,734,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Director |
2010-12-01 |
909,891 |
2005-04-01 |
1,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-12-01 |
4 |
AB |
$4.90 |
$24,500 |
D/D |
5,000 |
854,057 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2010-12-01 |
4/A |
AB |
$4.90 |
$24,500 |
D/D |
5,000 |
909,891 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-11-01 |
4 |
AB |
$4.76 |
$23,800 |
D/D |
5,000 |
849,057 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-10-04 |
4 |
AB |
$4.99 |
$24,950 |
D/D |
5,000 |
844,057 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-09-01 |
4 |
AB |
$4.10 |
$20,500 |
D/D |
5,000 |
839,057 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-08-02 |
4 |
B |
$4.75 |
$23,750 |
D/D |
5,000 |
834,057 |
2.81 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-07-16 |
4 |
AB |
$4.98 |
$24,950 |
D/D |
5,000 |
829,057 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-06-01 |
4 |
AB |
$4.99 |
$24,950 |
D/D |
5,000 |
824,057 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-05-20 |
4 |
AB |
$4.89 |
$24,630 |
D/D |
5,000 |
819,057 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• • – |
2010-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
44,723 |
849,665 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2009-10-16 |
4 |
B |
$4.88 |
$90,243 |
D/D |
18,500 |
804,942 |
4.01 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2009-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
66,294 |
786,442 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
720,148 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-10-15 |
4 |
OE |
$5.33 |
$79,950 |
D/D |
15,000 |
710,148 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-10-15 |
4 |
AS |
$23.49 |
$352,380 |
D/D |
(15,000) |
695,148 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-10-01 |
4 |
AS |
$22.03 |
$264,312 |
D/D |
(12,000) |
694,969 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-10-01 |
4 |
OE |
$5.33 |
$101,925 |
D/D |
13,995 |
696,964 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-10-01 |
4 |
D |
$22.39 |
$40,660 |
D/D |
(1,816) |
695,148 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-09-17 |
4 |
AS |
$23.39 |
$280,728 |
D/D |
(12,000) |
694,969 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-09-17 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
706,969 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-09-04 |
4 |
AS |
$23.77 |
$285,180 |
D/D |
(12,000) |
694,969 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-09-04 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
706,969 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-08-15 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
706,969 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-08-15 |
4 |
AS |
$23.16 |
$277,860 |
D/D |
(12,000) |
694,969 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-08-01 |
4 |
AS |
$21.23 |
$254,784 |
D/D |
(12,000) |
694,969 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
